- US-listed companies
- AbbVie Inc.
- Income statement
AbbVie Inc. (ABBV) Income statement
Market cap
$349.5B
P/E ratio
83.8x
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 18,790 | 19,960 | 22,859 | 25,638 | 28,216 | 32,753 | 33,266 | 45,804 | 56,197 | 58,054 | 54,318 | 56,334 | 61,160 |
| Revenue growth (%) | - | ||||||||||||
| Cost of revenue | 4,581 | 4,426 | 4,500 | 5,833 | 7,040 | 7,718 | 7,439 | 15,387 | 17,446 | 17,414 | 20,415 | 16,904 | 18,204 |
| Selling, general & administrative | 5,352 | 7,724 | 6,387 | 5,855 | 6,275 | 7,399 | 6,942 | 11,299 | 12,349 | 15,260 | 12,872 | 14,752 | 14,010 |
| Operating margin (%) | |||||||||||||
| Operating expenses | 13,126 | 16,549 | 15,322 | 16,254 | 18,624 | 26,370 | 20,283 | 34,441 | 38,273 | 39,937 | 41,561 | 47,197 | 46,085 |
| Operating income | 5,664 | 3,411 | 7,537 | 9,384 | 9,592 | 6,383 | 12,983 | 11,363 | 17,924 | 18,117 | 12,757 | 9,137 | 15,075 |
| Income before tax | 5,332 | 2,369 | 6,645 | 7,884 | 7,727 | 5,197 | 8,426 | 3,398 | 12,989 | 13,477 | 6,250 | 3,716 | 6,597 |
| Pretax margin (%) | 28.4 | 11.9 | 29.1 | 30.8 | 27.4 | 15.9 | 25.3 | 7.4 | 23.1 | 23.2 | 11.5 | 6.6 | 10.8 |
| Provision for income taxes | 1,204 | 595 | 1,501 | 1,931 | 2,418 | -490 | 544 | -1,224 | 1,440 | 1,632 | 1,377 | -570 | 2,364 |
| Effective tax rate (%) | |||||||||||||
| Net income | - | - | - | 5,953 | 5,309 | 5,687 | 7,882 | 4,622 | 11,549 | 11,845 | 4,873 | 4,286 | 4,233 |
| Net income margin (%) | - | - | - | ||||||||||
| Earnings per share | 2.58 | 1.11 | 3.15 | 3.65 | 3.31 | 3.67 | 5.3 | 2.73 | 6.48 | 6.65 | 2.73 | 2.4 | 2.37 |
| Diluted EPS | 2.56 | 1.1 | 3.13 | 3.63 | 3.3 | 3.66 | 5.28 | 2.72 | 6.45 | 6.63 | 2.72 | 2.39 | 2.36 |
| Dividend payout ratio (%) | |||||||||||||
| Dividend per share | 2 | 1.75 | 2.1 | 2.35 | 2.63 | 3.95 | 4.39 | 4.84 | 5.31 | 5.71 | 5.99 | 6.29 | 6.65 |